While Suicide rates remain at a steady pace, "behavioral health" companies report massive profits

LifeStance Health Group (NASDAQ:LFST) exceeded Wall Street's revenue expectations in Q4 CY2025, with sales up 17.4% year on year to $382.2 million. The company's GAAP profit of $0.03 per share was significantly above analysts' consensus estimates. LifeStance Health Group's revenue guidance for Q1 CY2026 is optimistic at $390 million, 2.4% above analysts' estimates.